UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2025 Earnings Call Transcript November 6, 2025
UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.69, expectations were $-0.72.
Operator: Good morning, and thank you for standing by. Welcome to the UroGen Pharma Third Quarter 2025 Earnings Call. [Operator Instructions] Please be advised today’s conference is being recorded. I’d now like to go ahead and hand the conference over to your first speaker today, Vincent Perrone, Investor...
